DJIA 16,014.38 -12.67 -0.08%
NASDAQ 4,268.76 -14.99 -0.35%
S&P 500 1,852.21 -1.23 -0.07%
market minute promo

7.99 -0.03 (-0.37%)

REAL-TIME: Last trade at

company name or ticker

Recent Quotes

VNDA $7.99 -0.37%
1D 1W 3M 6M 1Y 2Y 3Y
Today's Open $7.85
Previous Close $8.02
Daily Range $7.73 - $8.20
52-Week Range $7.73 - $14.50
Market Cap $342.1M
P/E Ratio 5.57
Dividend (Yield) $0.00 (0.0%)
Volume 440,048
Average Daily Volume 656,924
Current FY EPS -$0.73




Drug Makers

Vanda Pharmaceuticals, Inc. (VNDA) Description

A biopharmaceutical company focused on the development and commercialization of clinical-stage drug candidates, with exclusive worldwide commercial rights to three product candidates in clinical development for various central nervous system disorders. Website:

News & Commentary Rss Feed

Meet The Pill That Might Cure Your Jet Lag

Vanda Pharmaceuticals is in Phase III trials for a new drug that could help millions of travelers.

Healthcare Trivia: 2 Truths and a Lie

Let's play a healthcare game to kick off the new year!

Vanda Pharmaceuticals (VNDA) Jumps: Stock Rises 7.9%

What I Like About Genocea

Vanda: The Long Case Strengthens

Why Vanda Pharmaceuticals' Shares Are Retreating Today

Slowing sales of the company's schizophrenia drug and ongoing losses are weighing down shares.

Mid-Morning Market Update: Markets Mostly Flat; Time Warner Beats Q3 Views

Vanda Pharmaceuticals' (VNDA) CEO Mihael Polymeropoulos on Q3 2015 Results - Earnings Call Transcrip

Vanda Pharmaceuticals' (VNDA) CEO Mihael Polymeropoulos on Q3 2015 Results - Earnings Call Transcript

Notable Tuesday Option Activity: CACC, VNDA, FNGN

Latest Developments Warrant A Deeper Look At Raptor Pharmaceuticals

See More VNDA News...

VNDA's Top Competitors

VNDA $7.99 (-0.37%)
Current stock: VNDA
AMGN $143.16 (0.11%)
Current stock: AMGN
GILD $87.25 (2.33%)
Current stock: GILD
BIIB $249.99 (-0.31%)
Current stock: BIIB